EN
HI
Summary
As of 21 Sep, 2026, Symbiotec Pharmalab stock price is ₹1095.1. During the trading session, the stock has moved between an intraday low of ₹1048.00 and an intraday high of ₹1106.90. Over the last 52 weeks, Symbiotec Pharmalab has traded between ₹934.20 and ₹1193.70.
The stock has recorded a trading volume of 10,99,366 shares,. Its Average Traded Price (ATP) is ₹1080.37, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 10 @ ₹1095.10.
Symbiotec Pharmalab has an upper circuit limit of ₹1314.10 and a lower circuit limit of ₹876.10. The total value traded stands at ₹118.77 CR, and the delivery percentage for the day is 35.84%.
The stock is currently traded with a market lot size of 1. Symbiotec Pharmalab also offers a dividend yield of 0%.
Symbiotec Pharmalab Share Price Chart
Symbiotec Pharmalab Share Key Metrics
Volume
10.99 L
Market Cap
7036.69 CR
LTQ@LTP
10@1095.10
ATP
1080.37
Var Margin
25 %
Circuit Range
876.1-1314.1
Delivery %
35.84 %
Value
118.77 CR
ASM/GSM
No
Market Lot
1
Symbiotec Pharmalab Fundamentals
P/E Ratio
63.92
P/B Ratio
4.73
Div. Yield
0
Sector P/E
42.35
Sector P/B
3.61
Sec. Div. Yield
0.51
Symbiotec Pharmalab Resistance and Support
Pivot 1083.33
Resistance
First Resistance
1118.66
Second Resistance
1142.23
Third Resistance
1177.56
Support
First Support
1059.76
Second Support
1024.43
Third Support
1000.86
Symbiotec Pharmalab Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 18 2026 | 1050 | 1095.09 | 4.73% | 1106.9 | 1048 |
| Thu Sep 17 2026 | 1040 | 1045.59 | 0.27% | 1057 | 1020.59 |
| Wed Sep 16 2026 | 1085 | 1042.8 | -3.45% | 1087.9 | 1021.54 |
Symbiotec Pharmalab Corporate Actions
| Date | Agenda |
|---|---|
| 2026-09-21 | Quarterly Results |
Symbiotec Pharmalab News
Symbiotec Pharmalab Ltd - 544889 - Board Meeting Intimation for Prior Intimation Of The Meeting Of The Board Of Directors Of Symbiotec Pharmalab Limited ('The Company') To Be Held On September 21, 2026
Symbiotec Pharmalab's Board of Directors will hold a meeting on Sep 21, 2026. The primary agenda includes considering and approving the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
Sep 11 2026 16:17:53
Symbiotec Pharmalab Ltd - 544889 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Symbiotec Pharmalab's promoters, including Satwani Holdings LLP and individuals, pledged 34.93 lakh equity shares, which is 5.44% of the company's capital. This encumbrance is for debentures issued by Satwani Holdings (India) Private Limited.
Sep 11 2026 12:30:21
Read More
Symbiotec Pharmalab Management
| Name | Position |
|---|---|
| Anil Satwani | Chairman & Managing Director |
| Hariharnath Buggana | Nominee Director |
Symbiotec Pharmalab Similar Stocks
Procter & Gamble Health Ltd.
5503.50
0.00 (0.00%)
Aarti Pharmalabs Ltd.
820.40
0.00 (0.00%)
Nephrocare Health Services Ltd.
743.35
0.00 (0.00%)
Bliss GVS Pharma Ltd.
681.85
0.00 (0.00%)
Sanofi India Ltd.
3087.40
0.00 (0.00%)
Kovai Medical Center & Hospital Ltd.
6226.00
0.00 (0.00%)
Morepen Laboratories Ltd.
120.90
0.00 (0.00%)
Innova Captab Ltd.
1179.80
0.00 (0.00%)
Senores Pharmaceuticals Ltd.
1402.60
0.00 (0.00%)
IOL Chemicals And Pharmaceuticals Ltd.
203.15
0.00 (0.00%)
Symbiotec Pharmalab FAQs
The Buying Price of Symbiotec Pharmalab share is 1095.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Symbiotec Pharmalab stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Symbiotec Pharmalab, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Symbiotec Pharmalab shares is 63.92. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Symbiotec Pharmalab shares is 4.73. Useful to assess the stock's value relative to its book value.
To assess Symbiotec Pharmalab’s valuation compare Sector P/E, P/B which are 42.35 & 3.61 with sector averages, along with growth rates and financial metrics.
The Market Cap of Symbiotec Pharmalab is 7036.69 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Symbiotec Pharmalab share price is 1193.70 & 934.20. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Symbiotec Pharmalab belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in SYMBIOTEC
